Description:
Beraprost is an analog of prostacyclin in which the unstable enol-ether has been replaced by a benzofuran ether function. It inhibits platelet aggregation in healthy subjects and in diabetic patients at similar doses.
- Molecular Weight: 420.49
- Molecular Formula: C24H29NaO5
Purity: >95%
Canonical SMILES:
CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)[O-])O)O.[Na+]
InChI:
InChI=1S/C24H30O5.Na/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28;/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28);/q;+1/p-1/b13-12+;
InChIKey: YTCZZXIRLARSET-UEIGIMKUSA-M
- Boiling Point: 572.1°C at 760 mmHg
- Appearance: White Solid
- Storage: Amber Vial, -20°C Freezer, Under Inert Atmosphere
Synonyms:
Beraprost sodium; 4-[2-hydroxy-1-[(E)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate sodium salt
More details are to be found on supplier website
